GERD Can Induce Occurrence of Rheumatoid Arthritis, but Not Vice Versa
Bidirectional Mendelian randomization analysis showed 69 percent increased risk for RA occurrence for GERD patients
Pembrolizumab Shows Survival Benefit for Patients With Renal Cancer
Significant improvement seen in overall survival with pembrolizumab versus placebo and across key subgroups
ctDNA-Based Detection of Residual Disease Prognostic for Resected CRC
ctDNA-based detection of molecular residual disease in response to adjuvant chemotherapy prognostic of outcomes
Ten Variants Suggest Link to Surgical, Nonsurgical Rhizarthrosis
Seven variants suggest association with surgical rhizarthrosis; all 10 variants differed significantly between treatment groups
FDA: CAR T-Cell Therapies May Increase Risk for Rare Secondary Cancers
Twenty-five reports of rare blood cancers in patients who had received CAR T-cell therapy prompted agency's warning
Dana Farber Cancer Center to Retract or Fix Dozens of Studies
Gene Therapy for Sickle Cell Disease Likely Cost-Effective at <$2 Million
Incremental cost-effectiveness ratios were $126,000 and $281,000 per QALY for two simulation models from a societal perspective
$250B of U.S. Health Costs Could Be Tied to Exposure to Chemicals in Plastics
Most of the cost burden is from polybrominated diphenylethers
Cancer Vaccine Safe, Induces T-Cell Responses for KRAS-Mutated Tumors
Lymph node-targeting Amphiphile vaccine is safe; correlation seen for efficacy with T-cell response
Clinical Breast Exam Rarely Detects Second Breast Cancer After DCIS
Second breast cancers were most often imaging-detected or patient-detected, with only 2.2 percent detected by physician
